Ambulatory treatment of acute myeloid leukemia (AML) with weekly oral idarubicin alone in poor-risk elderly patients.

被引：0
|
作者：
Anglaret, B
Belhabri, A
Chelghoum, Y
Renaudier, P
Troncy, J
Bouheddou, N
Peaud, PY
Chevalier, MP
Thomas, X
机构：
[1] Ctr Hosp, Valence, France
[2] Hop Edouard Herriot, Lyon, France
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4621
引用
收藏
页码：208B / 208B
页数：1
相关论文
共 50 条
  • [41] Treatment of Elderly Acute Myeloid Leukemia Patients
    Motyckova, Gabriela
    Stone, Richard M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2011, 12 (04) : 341 - 353
  • [42] Treatment of Elderly Acute Myeloid Leukemia Patients
    Gabriela Motyckova
    Richard M. Stone
    Current Treatment Options in Oncology, 2011, 12 : 341 - 353
  • [43] Treatment of Elderly Patients With Acute Myeloid Leukemia
    Thomas, Xavier
    Le Jeune, Caroline
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (01)
  • [44] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Andrea Kuendgen
    Gesine Bug
    Oliver G. Ottmann
    Detlef Haase
    Julie Schanz
    Barbara Hildebrandt
    Kathrin Nachtkamp
    Judith Neukirchen
    Ariane Dienst
    Rainer Haas
    Ulrich Germing
    Norbert Gattermann
    Clinical Epigenetics, 2011, 2 : 389 - 399
  • [45] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Schanz, Julie
    Hildebrandt, Barbara
    Nachtkamp, Kathrin
    Neukirchen, Judith
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    CLINICAL EPIGENETICS, 2011, 2 : 389 - 399
  • [46] Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia
    Parker, JE
    Pagliuca, A
    Mijovic, A
    Cullis, JO
    Czepulkowski, B
    Rassam, SMB
    Samartunga, IR
    Grace, R
    Gover, PA
    Mufti, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) : 939 - 944
  • [47] Phase II Study of Cladribine, Idarubicin, and Cytarabine (araC) in Patients with Acute Myeloid Leukemia (AML)
    Kadia, Tapan
    Cortes, Jorge E.
    Jabbour, Elias J.
    Daver, Naval
    Pemmaraju, Naveen
    Ravandi, Farhad
    Jain, Nitin
    Verstovsek, Srdan
    DiNardo, Courtney
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Burger, Jan A.
    Garcia-Manero, Guillermo
    Ohanian, Maro
    Konopleva, Marina
    Estrov, Zeev
    Wierda, William
    Brandt, Mark
    Fitch, Tina
    Borthakur, Gautam
    Kantarjian, Hagop M.
    BLOOD, 2015, 126 (23)
  • [48] ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS. ANALYSIS OF 102 CASES
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Ionita, C.
    Calamar, D.
    Oros, D.
    Ionita, M.
    HAEMATOLOGICA, 2016, 101 : 684 - 684
  • [49] INTENSIVE CHEMOTHERAPY FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    YIN, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 279 - 279
  • [50] Oral chemotherapeutic agents in elderly acute myeloid leukemia (AML) patients, a study from a developing country
    Mukhopadhyay, S.
    Chitalkar, P.
    Gupta, P.
    Roy, U.
    Mukhopadhyay, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345